Prothena reported $495.63M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 436.58M 296.75M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Akebia Therapeutics AKBA:US USD 144.76M 868K
ALKERMES ALKS:US USD 263.96M 9.31M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amgen AMGN:US USD 9.5B 4.3B
Biogen BIIB:US USD 3.68B 1.03B
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Exelixis EXEL:US USD 675.29M 48.29M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
Intra Cellular Therapies ITCI:US USD 135.36M 58.12M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Macrogenics MGNX:US USD 83.99M 62.52M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Prothena PRTA:US USD 495.63M 13.17M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Seattle Genetics SGEN:US USD 362.6M 2.27M
Ultragenyx Pharmaceutical RARE:US USD 391.65M 231.78M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
Vital Therapies VTL:US USD 72.77M 15.31M
YTE INCY:US USD 2.69B 255.24M